Advocates for Human Potential, Inc.

A Bureau of Justice Assistance (BJA) funded program provided by Advocates for Human Potential, Inc. (AHP)
in partnership with Treatment Alternatives for Safe Communities (TASC) and AdCare Criminal Justice Services (ACJS).


A Comprehensive Listing of What States Cover for Substance
Use Disorder, including Medications

New Manual on
Health Literacy

Once they obtain health coverage, RSAT participants need to maximize the benefits offered in terms of preventive and primary care to promote both better physical and behavioral health.

Prison/Jail Medication Assisted Treatment Manual

Once you've seen the video, read the details of these exemplary programs.


Other Prison/Jail MAT Manuals

Rhode Island Vivitrol Manual
Rhode Island Suboxone SOP
Rhode Island Distribution of Suboxone Protocol
Kentucky MAT Manual
Massachusetts Department of Correction Medication Assisted Treatment Re-Entry Initiative (MATRI) Clinical Guidelines
Vermont MAT for Inmates: Work Group Evaluation Report and Recommendations
New Hampshire DOC MAT and Naltrexone Oral Augmentation Clinical Guidelines
Department of Vermont Health Access, Managed Care Entity, Vermont Buprenorphine Clinical Practice Guidelines, August 2015

Correctional MAT Videos

SAMHSA Video: Benefits and Cost Savings of MAT
Services in a Correctional Setting

This video features presentations from Jon Berge, SAMHSA, Mark Parrino, American Association for the Treatment of Opioid Dependence, Andrew Klein, RSAT TTA and Advocates for Human Potential, Kathleen Maurer, Connecticut DOC, and Kevin Pangburn, Kentucky DOC.

Montgomery County Corrections

Montgomery County, Maryland Department of Correction and Rehabilitation
video on that institution’s MAT Program

Massachusetts Department of Corrections

Brief descriptions of some Prison and Jail MAT Programs

Kentucky Prison, Massachusetts Prison, Philadelphia Jail, Rhode Island Prison,
West Virginia Prison, Wisconsin, Sacramento Jail, New Haven and Bridgeport Jails (Administered by state DOC), Kenton County, Kentucky Jail, Montgomery County, Maryland Jail, Barnstable County, Massachusetts Jail, Middlesex County, New York City Jail, and Salt Lake City Jail

Pennsylvania’s Medication Assisted Treatment (MAT) Pilot Program For Justice-Involved Individuals


Report on New Hampshire DOC MAT in Custody
Naltrexone Program

MAT Resources 

Substance Abuse Facilities-Opioid Treatment Services,
SAMHSA Feb. 2017

Map of Opioid Treatment Providers

SAMHSA’s Pocket Guide to Medication-assisted Treatment for Opioid Use Disorders

Link to PDF:

Link to SAMHSA Store page on this item:

FDA Newly Issued ‘Boxed’ warning on the dangers of combining opioids and benzodiazepines

Link to the FDA Drug Safety Announcement:

Link to PDF of Safety Announcement:

RSAT Jail Program Tour

What Inmates Tell us About RSAT

  • Opioid Treatment Drugs Have Similar Outcomes Once Patients Initiate Treatment

    This NIDA study compares buprenorphine/naloxone combination to extended release naltrexone. It is the second that now finds the two medications work equally well although one is an opioid substitute and the other an opioid (and alcohol) blocker.

  • Addressing the Substance Use Treatment and Aftercare Needs of Incarcerated Individuals: Challenges and Solutions Identified in the 2017 RSAT Evaluation

    This article summarizes a Justice Department Study of RSAT aftercare programs. It includes a good description on how RSAT is funded across the country as well as barriers and solutions to linking to aftercare.

  • Prison Health Care Costs and Quality

    The PEW Charitable Trust and VERA Institute of Justice surveyed state corrections to review what each was doing about health care for those incarcerated. They found that collectively, state correctional departments spend over $8 billion a year on prison health services (FY 2015), about 20% of all prison costs. Costs per individual vary dramatically, from just $2,173 in Louisiana to $19,796 in California. Treating chronic conditions has emerged as a growing challenge and expense, made worse as the prison population ages. 35 states systems monitor for quality of care, but only a handful indicate they take steps to require quality monitoring and build in compliance oversight. More departments are recognizing the importance of linking released individuals to health care in the community. The study concludes that (w)ell-run, forward-thinking prison health care systems are vital to state aims of providing care to incarcerated individuals, protecting communities, strengthening public health, and spending money wisely.”

  • Analysis of Disparities and Factors that Elevate Overdose Fatality Risk among Women: Implications for RSAT Programs and Re-entry Planning

    Women recently released from jail or prison face an even greater risk of drug overdose fatality than re-entering men. This article suggests why that may be so that countermeasures may be constructed.

  • Addressing the Substance Use Treatment and Aftercare Needs of Incarcerated Individuals: Challenges and Solutions Identified in the 2017 RSAT Evaluation

    This Justice Department evaluation of RSAT aftercare programs begins with a description of how RSAT is administered among the various states and U.S. territories. It then looks at RSAT aftercare programming, including the 11 RSAT programs funded as residential aftercare as opposed to prison or jail RSAT programs. It examines the challenges they faced and the strategies employed to overcome them.

  • Cooking them to Death: The Lethal Toll of Hot Prisons

    The Marshall Project reports on prison and jail deaths associated with rising temperatures in unairconditioned cells. Adding to the risk of increasing temperatures, many inmates are especially vulnerable if they are on psychotropic medications or medications for high blood pressure or elderly. Some individuals stop taking medication to cope with the heat, but then suicide risks increase. In Texas prisons, suicide attempts rose form 93 in March to 130 in August. More than 20 incarcerated have died from heat-related causes since 1998 in Texas where most prisons lack air conditioning. Texas has also paid out ½ a million dollars to correctional officers in workers comp claims for heat-related illness and injuries over the last decade.

  • Experiences of three states implementing the Medicaid health home model to address opioid use disorder—Case studies in Maryland, Rhode Island, and Vermont

    These states use the Medicaid Health Home model specifically to address opioid use disorder, integrating agonist treatment with health care and social services. Reported as challenging but successful. These models may inform other treatment initiatives.

  • Top Mental Health Researcher Suggests Link Between Opioid Overdoses and Suicides

    The director of the National Institute of Mental Health writes that there may be a stronger link between the opioid epidemic and suicides than previously realized. He writes: “There is a lot of concern that many of the overdose deaths could be suicides. We need to learn more about the prevalence of suicidality amongst opioid addicted individuals.” It may not be enough to encourage sobriety, some may need encouragement to live!

  • The Life-Threatening Reality of Short Jail Stays

    Suicide rates in jails exceed those in state prisons or the general population. And they are increasing. The higher rates can be explained by increase in individuals jailed who have substance use or mental health disorders. A disproportionate number of these deaths occur within the first few days of commitment underscoring the necessity of immediate assessment of individuals as soon as initial screening reveals substance use or mental disorders.

  • FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks

    Based on our additional review, the U.S. Food and Drug Administration (FDA) is advising that the opioid addiction medications buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system (CNS). The combined use of these drugs increases the risk of serious side effects; however, the harm caused by untreated opioid addiction can outweigh these risks. Careful medication management by health care professionals can reduce these risks.

  • With Opioid Crisis, a Surge in Hepatitis C

    The opioid crisis spurs hepatitis C infection growth with overdose deaths and infections rising in tandem especially across Appalachian, Midwestern and New England states. After declining for two decades, new hepatitis C cases have increased to an estimated 34,000 in 2015, nearly triple that of 2010 according to the CDC. While highly effective, and highly expensive new drugs and better screening for the blood born disease could eradicate it, experts agree that without stopping the opioid epidemic, or getting all those addicted to use clean needles, hepatitis C will continue to spread. It already affects 3.5 million Americans.

  • President’s Commission on Combating Drug Addiction and the Opioid Crisis

    The President’s Opioid Commission’s interim report is our recommending that with 141 overdose deaths a day, the President declare a national emergency. The report also urges expansion of MAT and naloxone distribution.

  • Drug Use, Dependence, and Abuse Among State Prisoners and Jail Inmates

    New BJS data reveal that 58% of state prisoners and 63% sentenced to jail suffer from substance use disorders. Rates were higher for females, at 69% and 72% respectively. Whites had higher rates than black or Hispanics in prisons and jails.

  • When twisted justice stops prisoners from
    starting over

    This USA Today article catalogues the thousands of legal restrictions persons reentering from prison face that inhabit their abiliyt to function in the free world.

  • Promising Practices Archive

Information on Effective Cognitive Behavioral Approaches

Participate in our forum!

Our jail is beginning a buprenorphine MAT program. My question is what should we do about individuals who are already on a methadone maintenance program when they are incarcerated? We won’t be offering methadone. Can they be switched if they choose?